# Treating Hearing Loss to Improve Mood and Cognition in Older Adults

> **NCT03321006** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 25 (actual)

## Conditions studied

- Hearing Loss
- Depression

## Interventions

- **DEVICE:** Phonak Audeo B-R 90 hearing aid device (Active)
- **DRUG:** Duloxetine or escitalopram
- **DEVICE:** Audeo B-R 90 hearing aid device (Sham)

## Key facts

- **NCT ID:** NCT03321006
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-06-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321006, "Treating Hearing Loss to Improve Mood and Cognition in Older Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03321006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*